ALOX12 and Hyperoxaluria: Because there were parallel changes in TRPV1, ALOX12, and NLRP3 expression as well as caspase-1 activation and IL-1β formation in HP kidneys, we examined whether inhibition of TRPV1 would ameliorate hyperoxaluria-induced renal inflammation and tubular injury.